These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 19934280

  • 1. Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice.
    Rovina N, Nikoloutsou I, Katsani G, Dima E, Fransis K, Roussos C, Gratziou C.
    Ther Adv Respir Dis; 2009 Dec; 3(6):279-87. PubMed ID: 19934280
    [Abstract] [Full Text] [Related]

  • 2. Smoking cessation treatment in a real-life setting: the Greek experience.
    Rovina N, Nikoloutsou I, Dima E, Michailidou M, Roussos C, Gratziou C.
    Ther Adv Respir Dis; 2007 Dec; 1(2):93-104. PubMed ID: 19124351
    [Abstract] [Full Text] [Related]

  • 3. Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
    Simon JA, Duncan C, Huggins J, Solkowitz S, Carmody TP.
    Nicotine Tob Res; 2009 Jun; 11(6):663-9. PubMed ID: 19395688
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcomes at 1 year.
    Grassi MC, Enea D, Ferketich AK, Lu B, Nencini P.
    Nicotine Tob Res; 2009 Sep; 11(9):1114-21. PubMed ID: 19654237
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling.
    McCarthy DE, Piasecki TM, Lawrence DL, Jorenby DE, Shiffman S, Fiore MC, Baker TB.
    Nicotine Tob Res; 2008 Apr; 10(4):717-29. PubMed ID: 18418793
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bupropion and cognitive-behavioral therapy for smoking cessation in women.
    Schmitz JM, Stotts AL, Mooney ME, Delaune KA, Moeller GF.
    Nicotine Tob Res; 2007 Jun; 9(6):699-709. PubMed ID: 17558827
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. No gender difference in effectiveness of smoking cessation treatment in a Brazilian real-life setting.
    Chatkin JM, Abreu CM, Blanco DC, Tonietto R, Scaglia N, Wagner MB, Fritscher CC.
    Int J Tuberc Lung Dis; 2006 May; 10(5):499-503. PubMed ID: 16704030
    [Abstract] [Full Text] [Related]

  • 18. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M, Oncken C, Gonzales D, Rennard S, Watsky EJ, Anziano R, Reeves KR.
    Arch Intern Med; 2006 May; 166(15):1561-8. PubMed ID: 16908788
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of Bupropion SR.
    Scharf D, Shiffman S.
    Addiction; 2004 Nov; 99(11):1462-9. PubMed ID: 15500599
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.